Integra Lifesciences released its Q2 2024 results this week.
Organic growth reconciliation figures show that Wound Reconstruction and Care sales within the Tissue Technologies division fell from US$ 192.1 m for Q2 YTD 2024 to US$ 168.6 m in Q2 YTD 2024.
https://investor.integralife.com/events-and-presentations
Integra Lifesciences released its Q2 2024 results this week....
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.72 |
Change
0.040(1.49%) |
Mkt cap ! $1.877B | |||
| Open | High | Low | Value | Volume |
| $2.69 | $2.78 | $2.66 | $5.438M | 1.988M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 30000 | $2.71 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.72 | 1776 | 1 |
View Market Depth
| Last trade - 16.10pm 01/08/2024 (20 minute delay) ? |
| PNV (ASX) Chart |